
Alexandra Rojek
@alexandrarojek
Heme/Onc fellow @UCCancerCenter and @KlineLabUChi, interested in aggressive lymphomas and cellular therapy; @JCO_ASCO editorial fellow. Views are my own.
ID: 2486619043
10-05-2014 03:45:37
325 Tweet
375 Followers
461 Following

ASCO weekend this year means celebrating UChicagoCancerCenter’s 50th anniversary in style with some Chicago architecture! We’re grateful to be a part of this great institution and excited for the next decades to come in cancer care! #ASCO24 University of Chicago Hematology/Oncology


It’s been an honor and such a phenomenal learning experience to be a Journal of Clinical Oncology editorial fellow this past year along with Giselle de Souza Carvalho, MD Rohit Singh, MD and Subodh Selukar - grateful to have learned from Suzanne Lentzsch, MD, PhD and Jonathan Friedberg among so many others!! ASCO #ASCO24


So excited to see this dream team take on the Journal of Clinical Oncology fellowship!! And excited to be a part of the journey as well. Congrats!! 🥳

#JCO welcomes our onboarding editorial fellows, Ayse Ece Cali Daylan, Michael Hughes, Peter Li, Joseph Mathew & @lcshihmd!



Our analysis of intensive chemo (IC) in CBF-AML (200 pt) is out in eJHaem Journal! Kudos to lead author Alexandra Rojek We found: -similar EFS/OS betw IC + GO & IC alone -longer 3y EFS w/ IC + KIT inhibitor (85%) we eagerly await NCT02013648 results! onlinelibrary.wiley.com/doi/10.1002/jh…


An amazing start to #AACRMBCO24 with University of Chicago Hem/Onc Fellows colleagues focusing on translational science in oncology! With some gorgeous summer days and scenery as a bonus 😎 AACR University of Chicago Hematology/Oncology @cannova_joe Dan Peiffer


The final version of our eJHaem Journal paper on intensive chemo strategies in CBF-AML is available! Alexandra Rojek #leusm -3y OS 70% and 3y EFS 51% for entire cohort -IC + GO 3y EFS 50%, IC alone 3y EFS 47%, IC + KIT inhibitor 3y EFS 85% onlinelibrary.wiley.com/doi/10.1002/jh…

We’re excited to see outstanding science talks at the Jonas Center for Cellular Therapy Symposium today University of Chicago Hematology/Oncology and updates on our lab’s work shared by Dr. Kline!


Amazing collaborations in this successful National Cancer Institute study led by Dr. Herrera. SWOG Cancer Research Network ECOG-ACRIN Cancer Research Group Children’s Oncology Group CCTG Alliance for Clinical Trials in Oncology Inclusive study enrolling pts aged 12+ with remarkable efficacy across all analyzed subgroups. Best-ever reported US results. nejm.org/doi/full/10.10…



ASCO ended over a week ago, but we're still thinking about how great it was! Highlights included: -Soni Smith MD's first ASCO conference on the Board of Directors -4 (!!) of our University of Chicago Hem/Onc Fellows winning YIAs -Rita Nanda as a FASCO recipient -30+ posters/presentations!
